Nemera, active in the design, development and manufacture of drug delivery solutions for the pharmaceutical, biotechnology and generics industries, announced a partnership with Zollner Elektronik AG, a major electronics manufacturing services (EMS) provider of electronic and mechatronic components.
As a partner, Zollner will support the design, development and manufacturing of electronic drug delivery systems for both Nemera's proprietary and customized products. The collaboration begins with Nemera's "Symbioze", a high-volume portable injection device. Nemera commissions Zollner to develop the electronics and software part of "Symbioze".
"From the very beginning, there has been a remarkable technological and human fit with Nemera to jointly develop pioneering solutions for a sustainable society. We are very pleased to be able to support our partner at the largest international trade fair for the pharmaceutical industry - CPHI 2022 - in Frankfurt in order to further deepen the already very intensive partnership and jointly open up new growth markets," says Erwin Stöckinger, Senior VP Business Division Electronics at Zollner Elektronik AG.
Bernhard Rohn, Strategy and Marketing Vice President at Nemera, said: "This strategic alliance strengthens both Nemera's and Zollner's offerings by combining knowledge of drug delivery devices and the pharmaceutical industry with knowledge of electronics development and manufacturing in the medical industry. Together we will strive to develop the devices of tomorrow for improved patient care."
As a provider of drug delivery solutions, Nemera puts patients first.
The company develops and manufactures devices that seek to maximize the effectiveness of treatment.
